| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/13/2011 | US20110009486 Method for treating pruritus by administering fullerenes |
| 01/13/2011 | US20110009485 Synthesis of scabronines and analogues thereof |
| 01/13/2011 | US20110009484 Disinfectant and method of making |
| 01/13/2011 | US20110009483 Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use |
| 01/13/2011 | US20110009482 Methods of treating copd |
| 01/13/2011 | US20110009481 Medicament for the treatment of viral skin and tumour diseases |
| 01/13/2011 | US20110009480 Biologically active taxane analogs and methods of treatment |
| 01/13/2011 | US20110009479 Stimulating Neuronal Growth Using Brevetoxins |
| 01/13/2011 | US20110009477 Oligonucleotide-based compounds as inhibitors of toll-like receptors |
| 01/13/2011 | US20110009476 Transcription factor decoys, compositions and methods |
| 01/13/2011 | US20110009475 Methods for treating stress induced emotional disorders |
| 01/13/2011 | US20110009474 Sirtuin based methods and compositions for treating beta-catenin-related conditions |
| 01/13/2011 | US20110009473 Pttg1 as a biomarker for cancer treatment |
| 01/13/2011 | US20110009472 RNAi Probes Targeting Cancer-Related Proteins |
| 01/13/2011 | US20110009471 Oligonucleotide analogues and methods utilizing the same |
| 01/13/2011 | US20110009470 Nucleic acid external skin formulation |
| 01/13/2011 | US20110009469 Compositions and methods of treating neoplasia |
| 01/13/2011 | US20110009468 Mirna, sirna and use thereof in therapy |
| 01/13/2011 | US20110009467 Methods to Increase or Decrease Bone Density |
| 01/13/2011 | US20110009466 Methods of increasing gene expression through rna protection |
| 01/13/2011 | US20110009465 3-phenoxymethylpyrrolidine compounds |
| 01/13/2011 | US20110009464 Immune system stimulation by light therapy induced apoptotic cell death in abnormal tissue |
| 01/13/2011 | US20110009463 Geranylgeranyl transferase inhibitors and methods of making and using the same |
| 01/13/2011 | US20110009461 2-aza-bicyclo[3.3.0]octane derivatives |
| 01/13/2011 | US20110009460 Compositions and methods for treating amyotrophic lateral sclerosis |
| 01/13/2011 | US20110009459 Epothilone derivatives |
| 01/13/2011 | US20110009458 Stable formulations of thiadiazole derivative |
| 01/13/2011 | US20110009457 Aminobenzamide Derivatives as Useful Agents for Controlling Animal Parasistes |
| 01/13/2011 | US20110009456 Compounds, Compositions and Methods for Treatment and Prevention of Orthopoxvirus Infections and Associated Diseases |
| 01/13/2011 | US20110009455 5-Oxo-2,3,4,5-tetrahydro-benzo[b]oxepine-4-carboxylic acid amides and 2,3-Dihydro-benzo[b]oxepine-4-carboxylic acid amides for treatment and prevention of Diabetes Typ 1 and 2 |
| 01/13/2011 | US20110009453 s1p3 receptor inhibitors for treating inflammation |
| 01/13/2011 | US20110009452 Hydroxyalkanyl amides as modulators of chemokine receptor activity |
| 01/13/2011 | US20110009451 Controlled delivery system |
| 01/13/2011 | US20110009450 Crystalline form of benzothiophene compound and process for preparation thereof |
| 01/13/2011 | US20110009449 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/13/2011 | US20110009448 Compound |
| 01/13/2011 | US20110009447 Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis |
| 01/13/2011 | US20110009446 Oligomer-guanidine class conjugates |
| 01/13/2011 | US20110009445 Neuroprotectants |
| 01/13/2011 | US20110009444 N-azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009443 Pyrazolospiroketone Acetyl-Coa Carboxylase Inhibitors |
| 01/13/2011 | US20110009442 Methods for stereoselective reduction |
| 01/13/2011 | US20110009441 Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| 01/13/2011 | US20110009440 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 01/13/2011 | US20110009439 Indene derivatives as pharmaceutical agents |
| 01/13/2011 | US20110009438 Substituted isoxazoline compound and pest control agent |
| 01/13/2011 | US20110009437 Carboxamide-heteroaryl derivatives for the treatment of diabetes |
| 01/13/2011 | US20110009436 Novel therapeutic uses of adrenergic alpha-1 receptor antagonists |
| 01/13/2011 | US20110009435 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions |
| 01/13/2011 | US20110009434 Crystals of isopropyl ester of n-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl -1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2h)-yl]-l- phenylalanine hydrochloride, production method thereof and use thereof |
| 01/13/2011 | US20110009433 Bicyclic pyrrole compound |
| 01/13/2011 | US20110009432 Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof |
| 01/13/2011 | US20110009431 Compositions and methods for treating fibroproliferative disorders |
| 01/13/2011 | US20110009430 Methods and compositions for treating pain |
| 01/13/2011 | US20110009429 Heterocyclic compounds as inhibitors of cxcr2 |
| 01/13/2011 | US20110009428 Novel androgens |
| 01/13/2011 | US20110009427 Aryl pyrimidine derivatives, preparation methods and pharmaceutical uses thereof |
| 01/13/2011 | US20110009426 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin ii receptor antagonists |
| 01/13/2011 | US20110009425 Tetrahydrothieno pyridines |
| 01/13/2011 | US20110009424 Co-Crystals and Pharmaceutical Compositions Comprising the same |
| 01/13/2011 | US20110009423 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 01/13/2011 | US20110009422 1- [2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition |
| 01/13/2011 | US20110009421 Compound having 6-membered aromatic ring |
| 01/13/2011 | US20110009420 Histamine H3 Receptor Ligands |
| 01/13/2011 | US20110009419 Enantiomers of 2'-Fluoralkyl-6-nitroquipazine as Serotonin Transporter Positron Emission Tomography Imaging Agents and Antidepressant Therapeutics |
| 01/13/2011 | US20110009418 Therapeutic agents useful for treating pain |
| 01/13/2011 | US20110009417 Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/13/2011 | US20110009416 PH INDEPENDENT FORMULATIONS OF 6-(5-CHLORO-2-PYRIDYL)-5-[(4-METHYL-1-PIPERAZINYL)CARBONYLOXY]-7-OXO-6,7-DIHYDRO-5H-PYRROLO[3,4-b]PYRAZINE |
| 01/13/2011 | US20110009415 Thienopyridazine Compounds, Their Preparations, Pharmaceutical Compositions And Uses |
| 01/13/2011 | US20110009414 Heterocyclic derivatives and their use as therapeutic agents |
| 01/13/2011 | US20110009413 Cyclic triazo and diazo sodium channel blockers |
| 01/13/2011 | US20110009412 Macrophage migration inhibitory factor antagonists and methods of using same |
| 01/13/2011 | US20110009411 Therapeutic compositions and the use thereof |
| 01/13/2011 | US20110009410 Apoptosis signal-regulating kinase inhibitors |
| 01/13/2011 | US20110009409 Dual-acting pyrazole antihypertensive agents |
| 01/13/2011 | US20110009408 Methods for identifiying inhibitors against viruses that use a class i fusion protein |
| 01/13/2011 | US20110009407 Pyridinone antagonists of alpha-4 integrins |
| 01/13/2011 | US20110009406 Tetrahydro-1h-pyrrolo fused pyridones |
| 01/13/2011 | US20110009405 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |
| 01/13/2011 | US20110009404 4-aryl-2-anilino-pyrimidines |
| 01/13/2011 | US20110009403 2-morpholinylpurines as inhibitors of pi3k |
| 01/13/2011 | US20110009402 Cyclic Inhibitors of 11Beta-Hydroxysteroid Dehydrogenase 1 |
| 01/13/2011 | US20110009401 2-aza-bicyclo[2.2.1]heptane derivatives |
| 01/13/2011 | US20110009400 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009399 Organic compounds |
| 01/13/2011 | US20110009398 p27 Protein Inducer |
| 01/13/2011 | US20110009397 Triazone compounds that modulate hsp90 activity |
| 01/13/2011 | US20110009396 Tricyclic compounds for the treatment of inflammatory disorders |
| 01/13/2011 | US20110009395 Bace inhibitors |
| 01/13/2011 | US20110009394 Tricyclic nitrogen compounds and their use as antibacterial agents |
| 01/13/2011 | US20110009393 Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof |
| 01/13/2011 | US20110009392 Gamma secretase modulators |
| 01/13/2011 | US20110009391 Tetrahydroquinoxaline urea derivatives, their preparation and their therapeutic application |
| 01/13/2011 | US20110009390 2-oxo-2- (2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl) -acetamide derivatives and related compounds as antifungal agents |
| 01/13/2011 | US20110009389 Imidazole derivative, their production and use |
| 01/13/2011 | US20110009388 Formulations and Methods of Administration of Cephalotaxines, Including Homoharringtonine |
| 01/13/2011 | US20110009387 Histone h2ax (hh2ax) biomarker for fti sensitivity |
| 01/13/2011 | US20110009386 Furo[3, 2-b] pyrr0l-3-0nes as cathespin s inhibitors |
| 01/13/2011 | US20110009385 Compounds |
| 01/13/2011 | US20110009384 Fused ring compounds as partial agonists of ppar-gamma |